Optogenetics and epilepsy: past, present and future.

PubWeight™: 1.04‹?› | Rank: Top 15%

🔗 View Article (PMC 4320957)

Published in Epilepsy Curr on February 14, 2015

Authors

Jeanne T Paz1, John R Huguenard2

Author Affiliations

1: Assistant Investigator, Gladstone Institute of Neurological Disease, UCSF, San Francisco, CA ; Consulting Assistant Professor of Neurology, Stanford School of Medicine, Stanford, CA ; Assistant Professor of Neurology and Neuroscience, University of California, San Francisco, CA.
2: Professor of Neurology, Stanford School of Medicine, Stanford, CA.

Articles citing this

Optogenetic tools for modulating and probing the epileptic network. Epilepsy Res (2015) 0.83

Implicating Interneurons: Optogenetic Studies Suggest That Interneurons Are Guilty of Contributing to Epileptiform Activity. Epilepsy Curr (2015) 0.79

Optogenetic Approaches for Controlling Seizure Activity. Brain Stimul (2016) 0.78

Seizing Control: From Current Treatments to Optogenetic Interventions in Epilepsy. Neuroscientist (2015) 0.77

Involvement of cortical fast-spiking parvalbumin-positive basket cells in epilepsy. Prog Brain Res (2016) 0.76

Illuminating the Undergraduate Behavioral Neuroscience Laboratory: A Guide for the in vivo Application of Optogenetics in Mammalian Model Organisms. J Undergrad Neurosci Educ (2016) 0.75

Illuminating the Role for Chloride Dysregulation in Network Activity. Epilepsy Curr (2016) 0.75

The antiepileptic and ictogenic effects of optogenetic neurostimulation of PV-expressing interneurons. J Neurophysiol (2016) 0.75

Illuminating the Cerebellum as a Potential Target for Treating Epilepsy. Epilepsy Curr (2015) 0.75

Optogenetic activation of VGLUT2-expressing excitatory neurons blocks epileptic seizure-like activity in the mouse entorhinal cortex. Sci Rep (2017) 0.75

Experimental assessment of the safety and potential efficacy of high irradiance photostimulation of brain tissues. Sci Rep (2017) 0.75

Chemically activated luminopsins allow optogenetic inhibition of distributed nodes in an epileptic network for non-invasive and multi-site suppression of seizure activity. Neurobiol Dis (2017) 0.75

Articles cited by this

Millisecond-timescale, genetically targeted optical control of neural activity. Nat Neurosci (2005) 28.08

Channelrhodopsin-2, a directly light-gated cation-selective membrane channel. Proc Natl Acad Sci U S A (2003) 15.17

Multimodal fast optical interrogation of neural circuitry. Nature (2007) 14.68

Neocortical excitation/inhibition balance in information processing and social dysfunction. Nature (2011) 8.25

The development and application of optogenetics. Annu Rev Neurosci (2011) 6.84

Characterization of engineered channelrhodopsin variants with improved properties and kinetics. Biophys J (2009) 4.75

Bi-stable neural state switches. Nat Neurosci (2008) 4.69

Optogenetic investigation of neural circuits underlying brain disease in animal models. Nat Rev Neurosci (2012) 4.35

Selective photostimulation of genetically chARGed neurons. Neuron (2002) 4.10

Optogenetic and potassium channel gene therapy in a rodent model of focal neocortical epilepsy. Sci Transl Med (2012) 3.53

Closed-loop optogenetic control of thalamus as a tool for interrupting seizures after cortical injury. Nat Neurosci (2012) 3.13

ReaChR: a red-shifted variant of channelrhodopsin enables deep transcranial optogenetic excitation. Nat Neurosci (2013) 2.98

A high-light sensitivity optical neural silencer: development and application to optogenetic control of non-human primate cortex. Front Syst Neurosci (2011) 2.72

Conversion of channelrhodopsin into a light-gated chloride channel. Science (2014) 2.56

Structure-guided transformation of channelrhodopsin into a light-activated chloride channel. Science (2014) 2.50

Thalamic synchrony and dynamic regulation of global forebrain oscillations. Trends Neurosci (2007) 2.47

On-demand optogenetic control of spontaneous seizures in temporal lobe epilepsy. Nat Commun (2013) 2.39

Optogenetic control of epileptiform activity. Proc Natl Acad Sci U S A (2009) 2.24

Chemical-genetic attenuation of focal neocortical seizures. Nat Commun (2014) 1.66

A new mode of corticothalamic transmission revealed in the Gria4(-/-) model of absence epilepsy. Nat Neurosci (2011) 1.66

Substantia nigra: site of anticonvulsant activity mediated by gamma-aminobutyric acid. Science (1982) 1.60

New insights into the function of M4 muscarinic acetylcholine receptors gained using a novel allosteric modulator and a DREADD (designer receptor exclusively activated by a designer drug). Mol Pharmacol (2008) 1.57

Thinking about the brain. Sci Am (1979) 1.42

Photothrombotic brain infarction results in seizure activity in aging Fischer 344 and Sprague Dawley rats. Epilepsy Res (2001) 1.27

Closed-loop optogenetic intervention in mice. Nat Protoc (2013) 1.12

Optogenetic delay of status epilepticus onset in an in vivo rodent epilepsy model. PLoS One (2013) 0.99

Chronic focal epilepsy induced by microinjection of tetanus toxin into the cat motor cortex. Electroencephalogr Clin Neurophysiol (1990) 0.96

Some cerebellar influences on electrically-induced cerebral seizures. Epilepsia (1955) 0.87

Tetanus toxin as a tool for studying epilepsy. J Physiol (Paris) (1984) 0.85